FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2040109 · Received April 5, 2011

Report

Report Number
2124215-2011-00508
Event Type
Malfunction
Date Received
April 5, 2011
Date of Event
January 5, 2011
Report Date
January 5, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

LATITUDE MONITORING OF THE LEAD WAS DISCUSSED. INFORMATION SUGGESTS THIS DEVICE AND LEAD REMAIN IN-SERVICE. INVESTIGATION IS COMPLETED AND THIS EVENT WILL BE UPDATED SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DETECTED ONE OUT OF RANGE HIGH PACING IMPEDANCES ON THIS TRANSVENOUS LEAD. IT WAS REPORTED THAT THE LEAD HAD BEEN STABLE AROUND 536 OHMS BUT DID NOTE A 1619 OHM MEASUREMENT AS WELL. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 81 YR 4469| E110| 0157| 1861